Intra Cellular Therapies reported $5.37B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 0.15B
ALKERMES ALKS:US 4.26B 0.49B
Aptinyx Inc APTX:US $ 0.15B 0.03B
Biocryst Pharmaceuticals BCRX:US $ 3B 0.51B
Biogen BIIB:US $ 30.95B 4.29B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Cytokinetics CYTK:US $ 3.15B 0.68B
Esperion Therapeutics ESPR:US $ 0.29B 0.02B
Gilead Sciences GILD:US $ 74.66B 16.42B
Halozyme Therapeutics HALO:US $ 5.49B 0.17B
Intra Cellular Therapies ITCI:US $ 5.75B 1.49B
JAZZ PHA JAZZ:US 9.61B 1.78B
Johnson & Johnson JNJ:US $ 466.05B 15.69B
Marinus Pharmaceuticals MRNS:US $ 0.35B 0.09B
Minerva Neurosciences NERV:US $ 0.04B 0B
Nektar Therapeutics NKTR:US $ 1B 1.49B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Novartis NVS:US 214.39B 0.43B
Prothena PRTA:US 1.71B 0.59B
Redhill Biopharma RDHL:US 0.13B 0B
Supernus Pharmaceuticals SUPN:US $ 1.72B 0.17B
United Therapeutics UTHR:US $ 8.12B 1.61B
Vanda Pharmaceuticals VNDA:US $ 0.63B 0.24B